Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover study of topical PSD503 versus placebo for female stress urinary incontinence
ISRCTN39853232Phase 2Completed
- Sponsor
- Plethora Solutions
- Start
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of phenylephrine in stress urinary incontinence (SUI) (2 arms), sponsored by Plethora Solutions. Primary endpoint: Change in pad weight gain on exercise stress pad test. Started Oct 2005; status: completed.
02
Drugs
phenylephrine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on ISRCTN39853232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN39853232.